Your browser doesn't support javascript.
Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids.
Wang, Bin; Ding, Yan; Zhao, Penghui; Li, Wei; Li, Ming; Zhu, Jingbo; Ye, Shuhong.
  • Wang B; School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning, 116034, China.
  • Ding Y; School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning, 116034, China. Electronic address: dingyan_515@hotmail.com.
  • Zhao P; School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning, 116034, China.
  • Li W; Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu, 41062, South Korea.
  • Li M; College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning, 116044, China.
  • Zhu J; School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning, 116034, China; Institute of Chemistry and Applications of Plant Resources, Dalian Polytechnic University, Dalian, Liaoning, 116034, China.
  • Ye S; School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning, 116034, China. Electronic address: hlcyeshuhong@hotmail.com.
Comput Biol Med ; 143: 105241, 2022 Jan 26.
Article in English | MEDLINE | ID: covidwho-1650900
ABSTRACT

BACKGROUND:

Recently, the value of natural products has been extensively considered because these resources can potentially be applied to prevent and treat coronavirus pneumonia 2019 (COVID-19). However, the discovery of nature drugs is problematic because of their complex composition and active mechanisms.

METHODS:

This comprehensive study was performed on flavonoids, which are compounds with anti-inflammatory and antiviral effects, to show drug discovery and active mechanism from natural products in the treatment of COVID-19 via a systems pharmacological model. First, a chemical library of 255 potential flavonoids was constructed. Second, the pharmacodynamic basis and mechanism of action between flavonoids and COVID-19 were explored by constructing a compound-target and target-disease network, targets protein-protein interaction (PPI), MCODE analysis, gene ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment.

RESULTS:

In total, 105 active flavonoid components were identified, of which 6 were major candidate compounds (quercetin, epigallocatechin-3-gallate (EGCG), luteolin, fisetin, wogonin, and licochalcone A). 152 associated targets were yielded based on network construction, and 7 family proteins (PTGS, GSK3ß, ABC, NOS, EGFR, and IL) were included as central hub targets. Moreover, 528 GO items and 178 KEGG pathways were selected through enrichment of target functions. Lastly, molecular docking demonstrated good stability of the combination of selected flavonoids with 3CL Pro and ACEⅡ.

CONCLUSION:

Natural flavonoids could enable resistance against COVID-19 by regulating inflammatory, antiviral, and immune responses, and repairing tissue injury. This study has scientific significance for the selective utilization of natural products, medicinal value enhancement of flavonoids, and drug screening for the treatment of COVID-19 induced by SARS-COV-2.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Comput Biol Med Year: 2022 Document Type: Article Affiliation country: J.compbiomed.2022.105241

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Comput Biol Med Year: 2022 Document Type: Article Affiliation country: J.compbiomed.2022.105241